Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague
DA Wagner, SM Kelly, AC Petersen, N Peroutka-Bigus… - Acta biomaterialia, 2019 - Elsevier
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
[PDF][PDF] Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague
DA Wagnera, SM Kellyb, AC Petersena… - Acta Biomater. Author …, 2020 - researchgate.net
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague
DA Wagner, SM Kelly, AC Petersen… - Acta …, 2019 - pubmed.ncbi.nlm.nih.gov
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.
DA Wagner, SM Kelly, AC Petersen… - Acta …, 2019 - europepmc.org
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
[HTML][HTML] Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague
DA Wagner, SM Kelly, AC Petersen… - Acta …, 2019 - ncbi.nlm.nih.gov
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.
DA Wagner, SM Kelly, AC Petersen… - Acta …, 2019 - europepmc.org
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …
left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however …